Home > Insider Trading > Filing (0001209191-18-051478)

Filing Details

Accession Number:: 0001209191-18-051478
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-18 16:33:51
Reporting Period:: 2018-09-14

Accepted Time:: 2018-09-18 16:33:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180262	Herbalife Nutrition Ltd.	HLF	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1311282	David Pezzullo	800 W. Olympic Blvd Suite 406 Los Angeles CA 90015	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-09-14	33,070	$55.64	157,940	No	4	S	Direct
Common Stock	Acquisiton	2018-09-14	63,934	$22.40	221,874	No	4	M	Direct
Common Stock	Disposition	2018-09-14	25,743	$55.62	196,131	No	4	D	Direct
Common Stock	Disposition	2018-09-14	18,936	$55.62	177,195	No	4	F	Direct
Common Stock	Acquisiton	2018-09-14	37,528	$29.99	214,723	No	4	M	Direct
Common Stock	Disposition	2018-09-14	20,235	$55.62	194,488	No	4	D	Direct
Common Stock	Disposition	2018-09-14	8,574	$55.62	185,914	No	4	F	Direct
Common Stock	Acquisiton	2018-09-14	106,034	$15.22	291,948	No	4	M	Direct
Common Stock	Disposition	2018-09-14	29,016	$55.62	262,932	No	4	D	Direct
Common Stock	Disposition	2018-09-14	38,187	$55.62	224,745	No	4	F	Direct
Common Stock	Disposition	2018-09-18	66,805	$55.12	157,940	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2018-09-14	63,934	$0.00	63,934	$22.40
Common Stock	Stock Appreciation Rights	Disposition	2018-09-14	37,528	$0.00	37,528	$29.99
Common Stock	Stock Appreciation Rights	Disposition	2018-09-14	106,034	$0.00	106,034	$15.22

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2015-05-31	2022-05-31	No	4	M	Direct
2017-04-30	2024-04-30	No	4	M	Direct
2018-03-02	2025-03-02	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018.
This transaction was executed in multiple trades at prices ranging from $55.06 to $56.04. The price reported reflects the weighted average sale price of $55.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 95,505 additional shares of common stock.
The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62.
The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62.
The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62.
This transaction was executed in multiple trades at prices ranging from $54.65 to $55.59. The price reported reflects the weighted average sale price of $55.12. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These SARS were previously reported as covering 31,967 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
These SARS were previously reported as covering 18,764 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
These SARS were previously reported as covering 53,017 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.